NASDAQ:PDEX Pro-Dex (PDEX) Stock Price, News & Analysis $66.92 +3.25 (+5.10%) Closing price 04/24/2025 04:00 PM EasternExtended Trading$61.96 -4.96 (-7.41%) As of 08:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Pro-Dex Stock (NASDAQ:PDEX) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Pro-Dex alerts:Sign Up Key Stats Today's Range$63.69▼$70.2650-Day Range$32.00▼$66.9252-Week Range$16.84▼$70.26Volume77,804 shsAverage Volume25,452 shsMarket Capitalization$218.23 millionP/E Ratio33.29Dividend YieldN/APrice Target$52.00Consensus RatingBuy Company OverviewPro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.Read More… Pro-Dex Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks29th Percentile Overall ScorePDEX MarketRank™: Pro-Dex scored higher than 29% of companies evaluated by MarketBeat, and ranked 789th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.5 / 5Analyst RatingBuy Consensus RatingPro-Dex has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoveragePro-Dex has received no research coverage in the past 90 days.Read more about Pro-Dex's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings Growth3.00% Earnings GrowthEarnings for Pro-Dex are expected to grow by 3.00% in the coming year, from $2.00 to $2.06 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Pro-Dex is 33.29, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.78.Price to Earnings Ratio vs. SectorThe P/E ratio of Pro-Dex is 33.29, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 22.19.Price to Book Value per Share RatioPro-Dex has a P/B Ratio of 6.86. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Pro-Dex's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.99% of the float of Pro-Dex has been sold short.Short Interest Ratio / Days to CoverPro-Dex has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pro-Dex has recently increased by 38.22%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldPro-Dex does not currently pay a dividend.Dividend GrowthPro-Dex does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.99% of the float of Pro-Dex has been sold short.Short Interest Ratio / Days to CoverPro-Dex has a short interest ratio ("days to cover") of 1.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Pro-Dex has recently increased by 38.22%, indicating that investor sentiment is decreasing significantly. News and Social Media3.8 / 5News Sentiment0.87 News SentimentPro-Dex has a news sentiment score of 0.87. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.74 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Pro-Dex this week, compared to 1 article on an average week.Search Interest7 people have searched for PDEX on MarketBeat in the last 30 days. This is an increase of 133% compared to the previous 30 days.MarketBeat Follows7 people have added Pro-Dex to their MarketBeat watchlist in the last 30 days. This is an increase of 600% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Pro-Dex insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,304,758.00 in company stock.Percentage Held by Insiders47.50% of the stock of Pro-Dex is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 15.28% of the stock of Pro-Dex is held by institutions.Read more about Pro-Dex's insider trading history. Receive PDEX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pro-Dex and its competitors with MarketBeat's FREE daily newsletter. Email Address PDEX Stock News HeadlinesPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 842 SharesApril 2, 2025 | insidertrades.comPro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot Sells 836 SharesApril 1, 2025 | insidertrades.comDividendStocks for BeginnersIf you’re not familiar with how to build a strong, reliable dividend portfolio… or where to begin… We’ve got the hookup for you. A young investor who’s obsessed with dividends put together a set of 5 dividend “cheat sheets” meant to take you from 0 to what could be a full blown dividend portfolio as quickly as possible… The best part? Right now, the five dividend cheat sheets are FREEApril 25, 2025 | ProsperityPub (Ad)Insider Selling: Pro-Dex, Inc. (NASDAQ:PDEX) Director Sells 3,096 Shares of StockMarch 28, 2025 | insidertrades.comWith 38% ownership in Pro-Dex, Inc. (NASDAQ:PDEX), hedge funds investors have a lot riding on the businessMarch 11, 2025 | finance.yahoo.comPro Dex director Cabillot sells shares worth $560,229January 28, 2025 | msn.comPro dex director Raymond Cabillot sells shares worth $94,577January 24, 2025 | msn.comPro Dex Inc director Raymond Cabillot sells $409,925 in stockJanuary 22, 2025 | msn.comSee More Headlines PDEX Stock Analysis - Frequently Asked Questions How have PDEX shares performed this year? Pro-Dex's stock was trading at $46.75 at the start of the year. Since then, PDEX shares have increased by 43.1% and is now trading at $66.92. View the best growth stocks for 2025 here. How were Pro-Dex's earnings last quarter? Pro-Dex, Inc. (NASDAQ:PDEX) issued its earnings results on Thursday, January, 30th. The medical instruments supplier reported $0.61 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.38 by $0.23. Pro-Dex had a trailing twelve-month return on equity of 21.68% and a net margin of 11.06%. Who are Pro-Dex's major shareholders? Top institutional shareholders of Pro-Dex include Ritholtz Wealth Management (0.49%). Insiders that own company stock include Alisha Charlton and Angelita Rebamontan Domingo. View institutional ownership trends. How do I buy shares of Pro-Dex? Shares of PDEX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pro-Dex own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pro-Dex investors own include NVIDIA (NVDA), Broadcom (AVGO), Novo Nordisk A/S (NVO), Adobe (ADBE), ServiceNow (NOW), Arista Networks (ANET) and Jabil (JBL). Company Calendar Last Earnings1/30/2025Today4/24/2025Next Earnings (Estimated)5/01/2025Fiscal Year End6/30/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:PDEX CIK788920 Webwww.pro-dex.com Phone(949) 769-3200Fax949-769-3281Employees140Year FoundedN/APrice Target and Rating Average Stock Price Target$52.00 High Stock Price Target$52.00 Low Stock Price Target$52.00 Potential Upside/Downside-22.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$2.01 Trailing P/E Ratio33.29 Forward P/E Ratio33.46 P/E GrowthN/ANet Income$2.13 million Net Margins11.06% Pretax Margin14.34% Return on Equity21.68% Return on Assets12.40% Debt Debt-to-Equity Ratio0.33 Current Ratio2.58 Quick Ratio1.44 Sales & Book Value Annual Sales$61.00 million Price / Sales3.58 Cash Flow$1.92 per share Price / Cash Flow34.81 Book Value$9.76 per share Price / Book6.86Miscellaneous Outstanding Shares3,261,000Free Float1,712,000Market Cap$218.23 million OptionableNot Optionable Beta0.40 Social Links Free Today: Your Guide to Smarter Options TradesLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:PDEX) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pro-Dex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pro-Dex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.